investiment.io
VolitionRx Limited
$0.7
-0.02 (-2.61%)
VolitionRx Limited
$0.7
-0.02 (-2.61%)
VNRX Price Chart
| Basic | |
|---|---|
| Market Cap | $64.28M |
| Price | $0.7 |
| 52 Week Range | 0.43-1.38 |
| Beta | 1.106 |
| Margins | |
| Gross Profit Margin | -40.42% |
| Operating Profit Margin | -3355.66% |
| Net Profit Margin | -3320.12% |
| Valuation (TTM) | |
| P/E Ratio | -1.78 |
| Price to Sales Ratio | 65.82 |
| Price to Book Ratio | -2.65 |
| PEG Ratio | -0.20 |
Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Mr. Cameron Reynolds MBA
Full-Time Employees
101
Website
IPO Date
2012-03-02
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.
Phone
646 650 1351
Address
13215 Bee Cave Parkway, Austin, TX, 78738, US
CIK
0000093314